Korean Drug Co., Ltd. (KOSDAQ:014570)

Korean Drug Revenue

Korean Drug had revenue of 13.34B KRW in the quarter ending March 31, 2026, with 1.92% growth. This brings the company's revenue in the last twelve months to 62.76B, down -6.01% year-over-year. In the year 2025, Korean Drug had annual revenue of 62.51B, down -14.37%.

• Revenue (ttm): 62.76B
• Revenue Growth: -6.01%
• P/S Ratio: 0.61
• Revenue / Employee: 232.45M
• Employees: 270
• Market Cap: 38.08B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	62.51B	-10.49B	-14.37%
Dec 31, 2024	73.00B	-8.37B	-10.29%
Dec 31, 2023	81.37B	1.39B	1.74%
Dec 31, 2022	79.98B	5.52B	7.41%
Dec 31, 2021	74.47B	7.68B	11.49%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 1, 2026

Data Sources Report a data error